Clinical Trial

Duloxetine Metabolism and Fibromyalgia

Study acronym: DILIGENT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
People with fibromyalgia report generalized body pain ("pain all over"), increased sensitivity to painful stimulation, chronic tiredness or low energy, sleep problems, and other physical and functional problems. The exact cause of the disorder is poorly understood, and treatment can be difficult. The degree to which duloxetine is helpful for people with fibromyalgia varies greatly. For some people, it is very helpful for managing fibromyalgia symptoms. For others, people may not notice any benefit. Yet for some, it is a little helpful and the effect is noticeable only when people forget to take the medicine. The purpose of this study is to collect data to better understand the relationship among gene types that control those enzymes, blood concentrations of duloxetine, and how it helps the symptoms.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-04; most recent amendment 2025-08-15.
Status change: Not Yet Recruiting → Recruiting 2025-05-12
Trial Details
NCT Number NCT06866444
Lead Sponsor University of Utah
Conditions Fibromyalgia, Duloxetine
Enrollment 100 participants
Start Date 2025-05-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-21